| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8740820 | Journal of Microbiology, Immunology and Infection | 2018 | 10 Pages |
Abstract
The increase of ceftriaxone resistance in pneumococci in part driven by PCV7 vaccination in Taiwan is worrisome. The use of PCV13 in children as well as in the elderly population is likely to offer protection from the infection caused by ceftriaxone-resistant pneumococci. It is important to give an effective drug such as penicillin, fluoroquinolones or vancomycin in 2 days for improving outcome of IPD patients.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Hao-Yuan Lee, Tsu-Lan Wu, Lin-Hui Su, Hsin-Chieh Li, Rajendra Prasad Janapatla, Chyi-Liang Chen, Cheng-Hsun Chiu,